Viva Final Prese 2

download Viva Final Prese 2

of 74

Transcript of Viva Final Prese 2

  • 7/31/2019 Viva Final Prese 2

    1/74

    Antimicrobial Activity ofEuryale

    ferox. Salisb:- A ThreatenedAquatic Plant of Kashmir

    Himalaya

    ByJavid Ahmad Parray

    M.Phil Research scholar

    Supervisor: Prof.(Dr.) Azra N. KamiliCo-Supervisor: Dr. Raies A. Qadri

    P.G Department of Environmental Science

    University of Kashmir

  • 7/31/2019 Viva Final Prese 2

    2/74

    INTRODUCTION

  • 7/31/2019 Viva Final Prese 2

    3/74

    Medicinal plants contain chemical substances which produce a definite

    physiological action on human body and animal system.

    Medicinal Plants

    Phenols and

    Mucilages

    Flavnoids

    Essential

    oils TanninsGlycosides

    Steroids

    Chemical substances

  • 7/31/2019 Viva Final Prese 2

    4/74

    pharmacological

    activities

    Antimicrobial

    Anti cancerous

    Stimulatory

    Anti-

    inflammatory

    Sedative

    Spasmolytic

    Secondary metabolites

  • 7/31/2019 Viva Final Prese 2

    5/74

    The main objective of the work was to determine theAntibacterial

    and Antifungalactivity ofEuryale ferox.

  • 7/31/2019 Viva Final Prese 2

    6/74

    Study Area

  • 7/31/2019 Viva Final Prese 2

    7/74

  • 7/31/2019 Viva Final Prese 2

    8/74

    Source: Department of Geology and Remote Sensing, University of Kashmir.

    Study Area- IRSP6-LISS III October Image of Mansabal lake

  • 7/31/2019 Viva Final Prese 2

    9/74

    PLANT

    PROFILE

  • 7/31/2019 Viva Final Prese 2

    10/74

    Parts StudiedSeeds, Rhizome,

    Petiole and Leaves.

    Euryale ferox

  • 7/31/2019 Viva Final Prese 2

    11/74Euryaleferox

  • 7/31/2019 Viva Final Prese 2

    12/74

    Domain Eukaryota

    Kingdom Plantae

    Subkingdom ViridaeplantaePhylum Tracheophyta

    Sub-phylum Euphyllophytina

    Infra-phylum Radiatopses

    Class MagnoliopsidaSub-class Nymphaeidae

    Super- order Nymphaeanae

    Order Nymphaeales

    Family NymphaeaceaeSub-family Euphorbioideae

    Tribe Euphorbie

    Genus Euryale

    Species E. Ferox

    Scientific Classification

    Source: http://Plants.gov/java/Euryale f erox/Classification Servelet

    http://zipcodezoo.com/Key/Plantae/Euphorbieae_Tribe.asphttp://zipcodezoo.com/Key/Plantae/Euphorbieae_Tribe.asphttp://zipcodezoo.com/Key/Plantae/Euphorbieae_Tribe.asp
  • 7/31/2019 Viva Final Prese 2

    13/74

    Bihar Madhubani

    English Fox nut

    Kashmir Jewer

    Punjabi Juwar

    Hindi Makhana

    Korean Ga-si-yeon-kot

    China Qianshi

    Japan Onibasu

    Sanskrit Mukhauna, Padma

    Vietnamese Khiem Thuc

    Source: http: //www. herbalextractplus.com/Euryale.cfm

    Different names of

    Euryale ferox

  • 7/31/2019 Viva Final Prese 2

    14/74

    An annual aquatic herb with rhizomatous stems,

    rhizome erect or repent and unbranched.

    Leaves directly arise from rhizomes and are of 4-

    10 cm in length with long petiolete.

    Floating leaves are prickly on petioles andalong veins.

    Leaf blade is abaxially dark purple and

    adaxially green and is 1.3-2.7 mm indiameter and primary veins are prickly on

    both surfaces .

    Seeds are very hard, remains dormant for year.

    Botanical Description

  • 7/31/2019 Viva Final Prese 2

    15/74

    China, Korea, Japan, Russia, Bangladesh,

    India and grows wild in J&K and is an non

    endemic threatened plant. (Khan et al.,

    2000; Dar et al., 2002).

    Distribution

  • 7/31/2019 Viva Final Prese 2

    16/74

    The plant has been traditionally used though out the

    world to cure many diseases including chronic-

    diarrhea, kidney problem, leucorrhea and hypo-

    function of spleen. (Brown, 1995). used as an analgesic, aphrodisiac, astringent,

    oxytonic and tonic in China (Duke et al.,

    1985).

    Leaves are used in the case of difficult parturition(Duke and Ayensu, 2003).

    The plant is internally taken to treat vaginal-

    discharge, impotence etc.(Brown, 1995).

    Medicinal Uses

  • 7/31/2019 Viva Final Prese 2

    17/74

    In Indian traditional system of medicines the dry seeds

    of the plant are being used as immuno-stimulant for

    mothers after child birth with relatively poor immune

    status (Puri et al., 2000). E. ferox also has been shown to enhance the activities of

    superoxide dismutase, catalase and glutathione

    peroxidase in V79-4 cells (Lee et al., 2002)

    Seed of this plant have cardio protective properties

    which may link with ability of makhana to induce

    TRP32 and TrX-1 protein and to scavenge ROS

    (Samarajit et al., 2006).

  • 7/31/2019 Viva Final Prese 2

    18/74

    Euryale ferox

  • 7/31/2019 Viva Final Prese 2

    19/74

    Seeds ofEuryale

    ferox

  • 7/31/2019 Viva Final Prese 2

    20/74

    METHODOLOGY

  • 7/31/2019 Viva Final Prese 2

    21/74

    Methodology involved:Selection and collection of the medicinal

    plant.

    Solvent extraction. Selection of specific bacterial and fungal

    strains.

    Antimicrobial assay Qualitative phyto-chemical screening

    METHODOLOGY

  • 7/31/2019 Viva Final Prese 2

    22/74

    Identification:Plant was identified at KASH,Department of Botany, University

    of Kashmir under Acc. No.1015.

    Collection: August -September 2008

    Identification andCollection

  • 7/31/2019 Viva Final Prese 2

    23/74

    The powder form of different plant parts

    (leaf, rhizome, petiole and seeds)

    collected were subjected to hotextraction (Soxhlet extraction).

    Solvents: Petroleum ether, Chloroform,

    and Methanol.

    Crude extraction of the

    sample

  • 7/31/2019 Viva Final Prese 2

    24/74

    Soxhlet extractor

  • 7/31/2019 Viva Final Prese 2

    25/74

    Fifty grams of dried powder ofeach plant part (leaf, rhizome,

    petiole and seed) were used.

    Extracts collected were later driedand weighed and kept for further

    process.

    Whole plant

    extraction

    Preparation of Discs

  • 7/31/2019 Viva Final Prese 2

    26/74

    :

    Preparation of mediaNutrient Agar Medium Dissolve 37.0 gm in 1000 ml of

    distilled water

    Nutrient Broth Suspend 8.0 gm in 1000 ml of

    distilled water.

    Muller Hinton Agar Dissolve 38.0 gm in 1000 ml of

    distilled water

    Muller Hinton Broth Suspend 21g of the powder in

    1000ml of distilled water.

    Blood Agar Suspend 40 g of the blood agar

    base in 1000 ml of distilled water.

    Sabourand Dextrose agar Dissolve 64 g in 1000ml of

    distlled water

    Preparation of Discs

    Dissolve 200 mg of extract in 25 ml of solvent.

    (1l=8g)

  • 7/31/2019 Viva Final Prese 2

    27/74

    Test Microorganisms

    Gram Positive Bacterial Strains

    Staphylococcusaureus I

    Staphylococcus aureus II

    Staphylococcus aureus III

    Pnemococcus spp.

  • 7/31/2019 Viva Final Prese 2

    28/74

    E. Coli I

    E. Coli II

    Pseudomonas aeruoginosa I

    Pseudomonas aeruoginosa II

    Proteus vulgaris

    Salmonella typhii

    Salmonella typhimurium

    Klebsiella pneumonia

    Acintobactersp

    Citrobacter fruendi

    Shigella flexneri

    Gram Negative Bacterial Strains

  • 7/31/2019 Viva Final Prese 2

    29/74

    Strains were provided by Bacteriological

    and Mycological section ( Department ofMicrobiology, SKIMS Soura. Srinagar.

  • 7/31/2019 Viva Final Prese 2

    30/74

    Disc diffusion method: (Nutrient Agar , MullerHinton Agar and Saboarnd Dextroser agar,Hi

    Media)

    Kirby-Bauer (Bauer et al, 2002)

    method was followed.

    SENSITIVITY TEST FOR ANTIMICROBIAL ASSAY

    Antimicrobial susceptibility Tests:

    The primary purpose of antimicrobial susceptibility testing isto determine the potency of crude drug.

    Sterile discs with antimicrobial agents are poured on microbialcultures and inhibition zone diameters (mm) around the discs are

    measured as the potency of crude plant extracts.

    Mixed culture of bacteria obtained from the polluted drain (that

    was spread on the nutrient agar plate) and twelve extracts ( 3 ofeach plant parts) were tested for antibacterial activity.

    Extracts which shows maximum activity ( methanol seed andmethanol leaf extract ) were than tested against specific bacterial and

    fungal strains.

    Dil i S ibili T

  • 7/31/2019 Viva Final Prese 2

    31/74

    Minimum inhibitory concentration(MIC)

    Minimum bactericidal concentration(MBC).

    Total activity (ml)

    Dilution Susceptibility Tests

  • 7/31/2019 Viva Final Prese 2

    32/74

    S. aureusATCC.25923

    E. coliATCC.25922

    Pseudomonasaeroginosa

    ATCC.27853

    Proteusvulgaris*

    Shigella

    flxmeriATCC.12022

    Salmonellatyphi*

    StandardATCCBacterial Strains

    Strains were provided by Bacteriological and Mycological section,

    Department of Microbiology, SKIMS Soura. Srinagar.

  • 7/31/2019 Viva Final Prese 2

    33/74

    Medium

    Muller Hinton Broth (Hi

    Media ) (NCCLS, 1990)

    i f i i f f

  • 7/31/2019 Viva Final Prese 2

    34/74

    Antimicrobial Conc.

    mg/l

    Volume of solution (ml) Distilled water (ml) Antimicrobial Conc.

    mg/l

    Final Conc. at 1:20

    dilution(g/ml)

    10000 1 9 1000 _

    10000 0.1 9.9 100 _100 1 9 10 _

    100 0.1 9.9 1 _

    10000 1 0 10000 500

    10000 0.512 0.488 5120 256

    10000 0.256 0.744 2560 128

    10000 0.128 0.872 1280 64

    1000 0.64 0.36 640 321000 0.32 0.68 320 16

    1000 0.16 0.84 160 8

    100 0.8 0.2 80 4

    100 0.4 0.6 40 2

    100 0.2 0.8 20 1

    10 1 0 10 0.5

    10 0.5 0.5 5 0.25

    10 0.25 0.75 2.5 0.125

    10 0.125 0.875 1.25 0.06

    1 0.625 0.375 0.625 0.03

    1 0.313 0.687 0.313 0.015

    1 0.156 0.844 0.156 0.008

    (As per Philips et al ., 1991)

    Preparation of dilutions of extracts for use

    in MIC determination

    Ph t h i l S i Q lit ti T t

  • 7/31/2019 Viva Final Prese 2

    35/74

    Phyto-chemical Screening Qualitative Tests

    Alkaloids

    Dragendorffs

    test

    Flavonoids

    NaOHand conc.

    HCl test

    Phenols

    Ferricchloridetest

    Glycosides

    Fehlingstest

    SteroidsLieberman-

    Burchards

    test

    TanninsFerricchloride test

    Saponins

    Frothingtest.

    Physiochemical standards ofUnani

    formulations- 1987

  • 7/31/2019 Viva Final Prese 2

    36/74

    By

    Isolation of Phyto-constituents

    Thin Layer

    chromatography

  • 7/31/2019 Viva Final Prese 2

    37/74

    RESULTS

    .

    A i i bi l i i f E l f i

  • 7/31/2019 Viva Final Prese 2

    38/74

    GPC= Gram Positive Cocii

    GNB= Gram Negative Bacillus

    + = Inhibitory activity

    - = No activity

    Pt = Petroleum ether extract

    C = chloroform extract

    M = methanol extract

    Antimicrobial activity ofEuryale ferox extracts against

    mixed culture of GPC & GNB bacteria.

    Strains Inhibition Zone Diameter (mm)

    Rhizome Petiole Leaf Seed

    Pt C M Pt C M Pt C M Pt C M

    Mixed culture of GPC& GNB bacteria.

    _ _ _ _ _ _ _ _ + _ _ +

  • 7/31/2019 Viva Final Prese 2

    39/74

    Strains Inhibition Zone Diameter (mm)

    Petroleum ether Chloroform Methanol

    Mixed culture of

    GPC & GNB

    bacteria.

    _ _ _

    GPC= Gram Positive Cocii

    GNB= Gram Negative Bacillus;

    + = Inhibitory activity

    - = No activity.

    Solvent Control

  • 7/31/2019 Viva Final Prese 2

    40/74

    GPC=Gram Positive Cocci

    GNB= Gram Negative

    Bacilli

    M=methanol

    Pt=Petroleum etherC=chloroform

    SM=Seed methanol

    SC=Seed chloroform

    SP= Seed pet ether

    LM=Leaf methanol

    LC=Leaf Chloroform

    LP=Leaf pet etherPM=Petiole methanol

    PC=Seed chloroform

    PP= Seed pet ether

    RM=Leaf methanol

    RC=Leaf Chloroform

    RP=Leaf pet ether

    FIG. 1a: Solvent extracts

    ofE. ferox

    FIG. 1b: Solvent Control

    Plate1: Mixed culture of GPC & GNB

  • 7/31/2019 Viva Final Prese 2

    41/74

    Fig 2a :E. coli Fig 2b:Staphylococcus aureus

    Plate 2: Effect of different concentrations of methanol seed extracts ofE.ferox on E.coli and Staphylococcus aureus

    SI = 5 l and S11 =55 l (seed methanol extract)

    Antibacterial activity of methanolic seed extracts of Euryale

  • 7/31/2019 Viva Final Prese 2

    42/74

    S.

    No.

    Strains Inhibition Zone Diameter (mm)*

    160 g 320 g Antibiotics

    01 S. aureus I 120.64 23 0.41 Erythromycin(25)

    02 S. aureus II 120.81 18 0.70 Vancomycin (20)

    03 S. aureus III 101.63 18 0.81 Cotrimaxozole (24)

    04 Pnemococcus spp 151.29 20 0.81 Lenzolid (22)

    * Results are mean diameter of zone of inhibition of three replicates followed by standard

    deviation; Methanol was taken as negative control and was found resistant in all strains.

    Antibacterial activity of methanolic seed extracts ofEuryale

    ferox against Gram Positive Bacterial strains.

    Antibacterial activity of methanolic leaf extracts of Euryale

  • 7/31/2019 Viva Final Prese 2

    43/74

    S. No Strains Inhibition Zone Diameter (mm) *

    160 g 320 g Antibiotic

    01 S. aureus I NA NA Erythromycin (25)

    02 S. aureus II 90.00 151.28 Vancomycin (20)

    03 S. aureus III 171.28 201.73 Cotrimaxozole (24)

    04 Pnemococcus

    spp

    121.07 160.40 Lenzolid (22)

    *Results are mean diameter of zone of inhibition of three replicates followed by standard

    deviation; Methanol was taken as negative control and was found resistant in all strains

    Antibacterial activity of methanolic leaf extracts ofEuryale

    ferox against Gram Positive Bacterial strains.

  • 7/31/2019 Viva Final Prese 2

    44/74

    Gram Positive Bacterial Strains

    Inh

    ibitionzonesDiameter(mm)

    Fig. 1: Comparative assessment of antibacterial activity of methanolic seed and leaf Extract ofE.

    ferox against Gram Positive Bacterial Strains (320g)

    Antibacterial activity of methanolic seed extracts of Euryale

  • 7/31/2019 Viva Final Prese 2

    45/74

    S. No. Strains Inhibition Zone Diameter (mm) *

    160 g 320 g Antibiotics01 E .coli I 12 1.15 15 0.00 Ceftazidime (30)

    02 E. coli II 16 2.16 22 1.63 Gentamycin (20)

    03 Pseudomonas aeroginosa I 18 2.82 28 0.81 Amikacin (15)

    04 Pseudomonas aeroginosa II 16 0.00 27 1.29 Gatifloxcin (20)

    05 Acintobacterspp 10 2.16 14 1.15 Piperacilin (0)

    06 Citrobacter freundii NA NA Vancomycin (22)

    07 Proteus vulgaris NA 19 1.41 Cefixime

    08 Shigella flexmeri 141.41 231.61 Ciprofloaxcin (29)

    09 Klebsiela pneumonia NA NA Gentamycin (25)

    10 Salmonella typhi 18 0.81 25 0.57 Imipenin (28)

    11 Salmonella typhimurum NA 15 1.28 Gatifloxcin (0)

    *Results are mean diameter of zone of inhibition of three replicates followed by standard

    deviation; Methanol was taken as negative control and was found resistant in all strains.

    Antibacterial activity of methanolic seed extracts ofEuryale

    ferox against Gram Negative Bacterial strains.

    Antimicrobial activity of methanolic leaf extracts of Euryale

  • 7/31/2019 Viva Final Prese 2

    46/74

    S. No. Strains Inhibition Zone Diameter (mm) *

    160 g 320 g Antibiotics01 E. coli I 8 1.22 100.16 Ceftazidime (30)

    02 E. coli II 13 0.42 200.41 Gentamycin (20)

    03 Pseudomonas aeroginosa I 16 1.10 22 0.24 Amikacin (15)

    04 Pseudomonas aeroginosa

    II

    17 1.24 21 0.81 Gatifloxcin (20)

    05 Acintobacter spp 10 0.16 16 0.40 Piperacilin (0)

    06 Citrobacter freundii NA NA Vancomycin (22)

    07 Proteus vulgaris NA 10 0.00 Cefixime

    08 Shigella flxmeri 12 0.74 18 0.21 Ciprofloaxcin (29)

    09 Klebsella pneumoniae NA NA Gentamycin (25)10 Salmonella typhi 11 0.08 21 0.14 Imipenin (28)

    11 Salmonella typhimurum NA 10 0.16 Gatifloxcin (0)

    *Results are mean diameter of zone of inhibition of three replicates followed by Standard

    deviation; Methanol was taken as negative control and was found resistant in all strains.

    Antimicrobial activity of methanolic leaf extracts ofEuryale

    ferox against Gram Negative Bacterial strains.

  • 7/31/2019 Viva Final Prese 2

    47/74

    Fig. 2: Comparative assessment of antibacterial activity of methanolic seed and leaf extract

    ofE. ferox against Gram Negative Bacterial Strains (320 g)

    InhibitionZonesD

    iameter(mm)

    Gram Negative Bacterial Strains

  • 7/31/2019 Viva Final Prese 2

    48/74

    Plate 3: Antibacterial activity of methanolic seed and leaf extract of

    E. ferox against S.aureus I and Pneumococcus spp

    Fig. 3a: S. aureus I Fig. 3b:Pneumococcus Spp.

    SI=160 g, S2=320 g= Seed methanol extract. L1=160 g,

    L2=320 g = Leaf methanol extract, Ab= Antibiotic; M= methanol

  • 7/31/2019 Viva Final Prese 2

    49/74

    Fig. 4a: S. aureus II Fig. 4b: S. aureus III

    Plate: 4 Antibacterial activity of methanolic seed and leaf extract ofE. ferox against

    S.aureus II and S.aureus IIISI=160 g, S2=320 g= Seed methanol extract. L1=160 g,

    L2=320 g = Leaf methanol extract, Ab= Antibiotic; M= methanol

  • 7/31/2019 Viva Final Prese 2

    50/74

    Fig. 5a: P. aureoginosa I Fig. 5b:P. aureoginosa II

    Plate 5: Antibacterial activity of methanolic seed and leaf extract ofE. ferox againstP.

    aureoginosa I and P. aureoginosa II

    SI=160 g, S2=320 g = Seed methanol extract. L1=160 g, L2=320 g = Leaf

    methanol extract, Ab= Antibiotic; M= methanol

  • 7/31/2019 Viva Final Prese 2

    51/74

    Fig. 6a: S. typhi Fig. 6b: E. coli I

    Fig. 6c:E. coli II

    Plate 6: Antibacterial activity of methanolic

    seed and leaf extract ofE. ferox against S.

    typhi,E. coli IandE. coli II.

    SI=160 g, S2=320 g = Seed methanol

    extract. L1=160 g, L2=320 g = Leafmethanol extract, Ab=Antibiotic;

    M=methanol

  • 7/31/2019 Viva Final Prese 2

    52/74

    Fig. 7a: Shigella flexnerii

    Plate 7: Antibacterial activity of methanolic seed and leaf extract ofE. ferox against Shigella

    flexnerii andAcintobacter spp.

    SI=160 g, S2=320 g = Seed methanol extract. L1=160 g, L2=320 g = Leaf methanol extract,

    Ab= Antibiotic; M=methanol

    Fig. 7b: Acintobacterspp.

  • 7/31/2019 Viva Final Prese 2

    53/74

    Fig. 8a: Citrobacter freundii

    Plate 8: Antibacterial activity of methanolic seed and leaf extract ofE. ferox against Citrobacter

    freundii and Klebsiella pneumonia

    SI=160 g, S2=320 g= Seed methanol extract. L1=160 g,L2=320 g = Leaf methanol extract, Ab= Antibiotic; M= methanol

    Fig. 8b: Klebsiella pneumonia

  • 7/31/2019 Viva Final Prese 2

    54/74

    Plate 9: Antibacterial activity of methanolic seed and leaf extract ofE. ferox against Salmonella

    typhimurium and Proteus vulgaris

    SI=160 g, S2=320 g= Seed methanol extract. L1=160 g,L2=320 g = Leaf methanol extract, Ab= Antibiotic; M= methanol

    Fig. 9b: Proteus vulgaris

    Fig. 9a: Salmonella typhimurium

    Minimum Inhibitory Concentration (MIC) of methanolic seed extract of

  • 7/31/2019 Viva Final Prese 2

    55/74

    S. No. Strains MIC MBC MIC

    Index

    Total

    Activity

    (ml)

    Gt. 10 g/ml

    MIC MBC

    01 S. aureus ATCC.25923 64 128 2.0 593.75 32 128

    02 E. coli ATCC.25922 128 256 2.0 296.87 128 500

    03 Pseudomonas aeroginosaATCC. 27853

    64 256 4.0 593.75 16 64

    04 Shigella flxmeri

    ATCC.12022

    ND ND _ _ ND ND

    05 Proteus vulgaris* 500 ND 76 256 500

    06 Salmonella typhi* 256 500 1.95 148.43 ND ND

    Methanol was used as negative control and exhibited no activity against tested organisms;

    ND = Non detectable within the range tested; * = isolated Strains; Gt. = Gentamicin

    MIC index = 4 (bactericidal) and = 4 (bacteriostatic)

    Total activity =highest value= highest inhibitory activity

    y

    Euryale ferox against standard bacterial strains (g/ml)

    .

    Minimum Inhibitory Concentration (MIC) of methanolic leaf extract of

  • 7/31/2019 Viva Final Prese 2

    56/74

    S. No. Strains MIC MBC MIC

    Index

    Total

    Activity

    (ml)

    Gt 10 g/ml

    MIC MBC

    01 S. aureus ATCC.25923 128 500 3.90 737.5 32 128

    02 E. coli ATCC.25922 256 500 1.95 368.75 128 500

    03 Pseudomonas aeroginosa

    ATCC.27853

    256 500 1.95 368.75 16 64

    04 Shigella flxmeri

    ATCC.12022

    500 ND ND 188.8 ND ND

    05 Proteus vulgaris* ND ND ND _ 256 500

    06 Salmonella typhi* 500 ND 188.8 ND

    Methanol was used as negative control and exhibited no activity against tested organisms;

    ND = non detectable within the range tested; * = isolated Strains; Gt. = Gentamicin.

    MIC index = 4 (bactericidal) and = 4 (bacteriostatic)

    Total activity =highest value= highest inhibitory activity

    y ( )

    Euryale ferox against standard bacterial strains (g/ml).

  • 7/31/2019 Viva Final Prese 2

    57/74

    Standard Bacterial Strains

    MIC(g/ml)

    Fig. 3: Comparative assessment of MIC of methanolic seed and leaf extract ofE. ferox

    against standard bacterial strains (g/ml)

  • 7/31/2019 Viva Final Prese 2

    58/74

    Fig. 4: Comparative assessment of MBC of methanolic seed and leaf extract of

    E. ferox against standard bacterial Strains (g/ml)

    Standard Bacterial Strains

    MBC(g/ml)

    g/ml)

  • 7/31/2019 Viva Final Prese 2

    59/74

    Fig. 5: Comparative assessment of Total activity of methanolic seed and leaf Extract ofE. ferox

    against standard bacterial Strains (ml)

    Totala

    ctivity(ml)

    Standard Bacterial Strains

    Antifungal activity of methanolic leaf and seed extract of Euryale ferox.

  • 7/31/2019 Viva Final Prese 2

    60/74

    S. No. Fungal Strains Leaf extract Seed extract

    200 g 400 g 200 g 400 g

    01 Crytococcus neoformans NA NA NA NA

    02 Aspergilus fumigates NA NA NA NA

    03 Candida albicans 9 0.81 16 0.70 70.3 12 0.81

    04 C. kruesie 8 0.48 100.28 70.3 9 0.00

    05 C.Stealoidea 10 0.62 150.34 80.2 11 0.5

    06 C. tropicals NA 150.34 NA 18 0.14

    07 C. parapsilosis NA NA NA NA

    08 Rhizopus spp NA NA NA NA

    09 Pencillum notatum 10 0.81 150.60 80.2 19 0.84

    *Results are mean diameter of zone of inhibition of three replicates followed by standard

    deviation; Nystatin was used as positive control and Methanol as negative control in all

    strains.

    Antifungal activity of methanolic leaf and seed extract ofEuryale ferox.

  • 7/31/2019 Viva Final Prese 2

    61/74

    Fig. 6: Comparative assessment of antifungal activity of methanolic Seed and Leaf

    extract ofE. ferox against fungal Strains (400 g).

    InhibitionZ

    oneDiameter(mm

    )

    Fungal Strains

  • 7/31/2019 Viva Final Prese 2

    62/74

    Fig. 10a: Aspergillus fumigates

    Plate 10: Antifungal activity of methanolic seed and leaf extract of

    E. ferox against Aspergillus fumigates and Cryptoccocus neoformans

    SI=200 g, S2=400 g = Seed methanol extract. L1=200 g, L2=400 g = Leaf methanol

    extract, Ab= Antibiotic; M=methanol

    Fig. 10b: Cryptoccocus neoformans

  • 7/31/2019 Viva Final Prese 2

    63/74

    Fig. 11a: C. parapsilosis

    Plate. 11: Antifungal activity of methanolic seed and leaf extract ofE. ferox against C.parapsilosis andRhizopus spp.

    SI=200 g, S2=400 g = Seed methanol extract. L1=200 g, L2=400 g = Leaf methanol extract,

    Ab= Antibiotic; M=methanol

    Fig. 11b:Rhizopus spp

  • 7/31/2019 Viva Final Prese 2

    64/74

    Fig. 12a: C. albicans

    Plate 12: Antifungal activity of methanolic seed and leaf extract ofE. ferox against C. albicans and

    C. kruesie

    SI=200 g, S2=400 g = Seed methanol extract. L1=200 g, L2=400 g = Leaf methanol extract,

    Ab= Antibiotic; M=methanol

    Fig. 12b: C. Kruesie

  • 7/31/2019 Viva Final Prese 2

    65/74

    Fig. 13a: P. notatum

    Plate 13: Antifungal activity of

    methanolic seed and leaf extract

    ofE. ferox against P. notatum

    C. stealoidea andC. tropicals .

    SI=200g, S2=400 g = Seed methanol

    extract.L1=200g,L2=400 g = Leaf

    methanol extract, Ab= Antibiotic;

    M=methanol

    Fig. 13c: C. tropicals

    Fig. 13b: C. stealoidea

    Ph h i l C i f M h li E f

  • 7/31/2019 Viva Final Prese 2

    66/74

    Constituents tested for Leaf extract Seed extract

    Alkaloids + +

    Steroids _ +

    Glycosides + +

    Phenols + +

    Tannins + +

    Saponins _ +

    Flavonoids + +

    - = Not present , + = Present.

    Phyto-chemical Constituents of Methanolic Extracts of

    Euryale ferox

  • 7/31/2019 Viva Final Prese 2

    67/74

    A= Petiole methanol extractB= Seed methanol extract

    C= Rhizome methanol extract

    D= Leaf methanol extract

    Solvent front =16.5cm

    A B C D

    Rf l f M h li f E l f

  • 7/31/2019 Viva Final Prese 2

    68/74

    Methanolic Extracts Rf. value

    Seed 0.176, 0.41, 0.58, 0.63 and 0.84

    Leaf 0.176, 0.35, 0.45 and 0.59

    Petiole 0.26

    Rhizome 0.11

    Solvent front = 17 cm

    solvents used = Chloroform: Methanol (7:3)

    Rf values of Methanolic extracts of Euryale ferox

    Extraction yield and macroscopic characteristics of the crude

    t t f E l f

  • 7/31/2019 Viva Final Prese 2

    69/74

    Name of the

    plant

    Common

    Name

    Solvent Part used Macroscopic characteristics Extract/

    yield (%)

    Euryale ferox Jewer

    Methanol

    Chloroform

    Petroleum ether

    SeedSeed

    Seed

    Black crystalline powderBrown crystalline powder

    Dark green shiny surface

    3.84

    3.07

    0.3

    Methanol

    ChloroformPetroleum ether

    Leaves

    LeavesLeaves

    Dark green shiny surface

    Dark green powderYellowish green powder

    9.44

    1.740.6

    Methanol

    Chloroform

    Petroleum ether

    Rhizome

    Rhizome

    Rhizome

    Dark black powder

    Dark green shiny surface

    A dark brown shiny surface

    7.88

    0.38

    1.76

    Methanol

    Chloroform

    Petroleum ether

    Petiole

    Petiole

    Petiole

    Dark green powder

    Brown crystalline powder

    Yellowish blue powder

    10.9

    0.98

    1.66

    extracts ofEuryale ferox

  • 7/31/2019 Viva Final Prese 2

    70/74

    CONCLUSION

    O l th li t t f d d l f hibit d hi h t

  • 7/31/2019 Viva Final Prese 2

    71/74

    Only methanolic extracts of seed and leaf exhibited highest

    antimicrobial activity.

    Seed extracts exhibited higher inhibitory activity than leaf

    extracts. Gram Positive strains were more susceptible than gram negative

    strains.

    Among the gram positive strains, S.aureusshows maximum zone of

    inhibition i.e highest inhibitory activity. However, IZD of some gram negative strains ( i.e. P. aureoginosa)

    were more than gram positive strains.

    Among the fungal strains, Candida spp. and Pencillum notatum

    were more susceptible to both extracts at higher

    concentrations.

    However C. neoformans,A. fumigates andRhizopus spp.

    C.Parapsilosiswere completely resistant.

    The results of MIC and MBC depicted that extracts ofE.

  • 7/31/2019 Viva Final Prese 2

    72/74

    p

    ferox can be bactericidal in action and among

    standard strains tested, S. aureus ATCC 25923 was

    inhibited by least concentration of extracts used. Phyto-chemical screening of methanolic seed and leaf

    extracts revealed the presence of alkaloids, phenols,

    flavonoids, steroids and tannins while as steroids

    and Saponins were present in only seed extract. The separation of methanolic extracts by thin layer

    chromatography (TLC) yields different compounds

    with seed extract showed five compounds of Rf

    values 0.176, 0.41, 0.58, 0.63 and 0.84 while as

    leaf extract yields four compounds with Rf. value of

    0.176, 0.35, 0.45 and 0.59.

    The substances that can inhibit pathogens and have

  • 7/31/2019 Viva Final Prese 2

    73/74

    p g

    a little toxicity to host cells are considered good

    for developing antimicrobial drugs.

    Therefore, the antimicrobial activity ofE. feroxextracts on these UTI organisms reveals that it can

    be safely used to treat these kinds of infections

    after proper drug formulation.

    The literature reveals that no prior work has been

    done on evaluating antimicrobial activity ofE.

    ferox and it is now expected after results that it

    will be helpful in obtaining broad spectrum herbal

    formulation as well as new antimicrobial

    substances.

  • 7/31/2019 Viva Final Prese 2

    74/74